Meeting on the Mesa 2026 has ended. This guide stays up as the record of who was there. Next: Meeting on the Mesa 2027, Oct 18–20, 2027 in Phoenix

Delivery and vectors at Meeting on the Mesa 2026

Oct 5–7, 2026 Phoenix, AZ ~1.5k attendees Website

65 organizations at Meeting on the Mesa 2026 present work in delivery: 34 suppliers and service providers and 31 therapy developers. Between them they bring 13 presentations to the program. 27 of them have their own page in this guide. As of Oct 6, 2026.

All 592 organizations at Meeting on the Mesa 2026 →

Format
Top represented
Showing 1–18 of 65 organizations
OrganizationMeeting on the Mesa 2026 Attendance
Viralgen
San Sebastian, Spain
◆Platinum Sponsor
CDMO & CROPlatinum Sponsor
Manufactures recombinant AAV vectors for gene therapy developers using a proprietary suspension platform and cGMP production facilities.
Spotlight
Tue, Oct 6
2:15pm
Attendee
GeneFab
Alameda, CA
◇Silver Sponsor
CDMO & CROSilver Sponsor
Contract research and manufacturing organization providing development and cGMP production for cell, gene, vector, mRNA, LNP and plasmid therapies.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
Genezen
Lexington, MA
◆Diamond Sponsor
CDMO & CRODiamond Sponsor
Genezen provides viral vector development and cGMP manufacturing for AAV, lentiviral, and retroviral gene and cell therapy programs, from concept through commercial supply.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
◆Gold Sponsor
Tools & equipmentGold Sponsor
Makes equipment for formulating and manufacturing lipid nanoparticles and other nanocarriers, from screening through GMP production.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
MaxCyte
Rockville, MD
◇Silver Sponsor
Tools & equipmentSilver Sponsor
Provides electroporation systems and genotoxicity testing services for genetic engineering, cell therapy development, and GMP manufacturing.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
Attendee
Oxford Biomedica Solutions
Oxford, United Kingdom
◇Silver Sponsor
CDMO & CROSilver Sponsor
Develops and manufactures viral vectors, including lentivirus, AAV and adenovirus, for cell and gene therapy developers from early development through commercialization.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
Attendee
Attendee
◇Bronze Sponsor
CDMO & CROBronze Sponsor
Provides CRO/CDMO services for AAV, lentiviral vectors, plasmid DNA, mRNA and LNPs, including process development, analytics, cell banking and GMP manufacturing.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
Wacker Biotech
Munich, Germany
◆Platinum Sponsor
CDMO & CROPlatinum Sponsor
Manufactures plasmid DNA, RNA and lipid nanoparticle formulations, providing development and GMP production for nucleic acid and gene therapy programs.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
Avectas
Dublin, Ireland
Tools & equipment
Provides Solupore, a non-viral cell-engineering and transfection platform for manufacturing gene-modified cell therapies.
Circio
Oslo, Norway
Cell & gene therapy
Develops circVec, a circular RNA expression platform that improves gene therapy potency and durability through AAV and LNP delivery.
Spotlight
Tue, Oct 6
9:15am
CPTx
Munich, Germany
Cell & gene therapy
Develops non-viral, duration-tunable in vivo CAR-T therapies using immune-quiet DNA vectors and targeted lipid nanoparticles.
CREATE Medicines
Cambridge, MA
Cell & gene therapy
Develops in vivo mRNA-LNP therapies that program immune cells, including CAR therapies for autoimmune diseases and cancer.
Emmecell
Menlo Park, CA
Cell & gene therapy
Develops magnetic cell-delivery technologies and regenerative cell therapies for corneal endothelial disease, geographic atrophy, and other eye conditions.
Latus Bio
Philadelphia, PA
Cell & gene therapy
Develops targeted gene therapies for genetic diseases including CLN2 and Huntington’s disease.
Mirai Bio
Cambridge, MA
Tools & equipment
Provides lipid nanoparticle delivery systems and development services for mRNA, RNA, DNA, and gene-editing medicines.
Spotlight
Tue, Oct 6
4:30pm
Innovation Spotlight company presentation
Nionyx Bio
New York City, NY
Cell & gene therapy
Develops human-selected AAV capsids and gene therapies for rare kidney diseases, targeting kidney cell types that are difficult to reach.
Spotlight
Mon, Oct 5
2:45pm
NTrans Technologies
Leiden, Netherlands
Cell & gene therapy
Develops nonviral intracellular delivery technology for CRISPR, base and prime editing, including therapies for genetic diseases.
Cell & gene therapy
Develops single-administration AAV gene therapies for chronic hepatitis B, CMV prevention, and other serious viral diseases.

Explore the full Meeting on the Mesa 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full Meeting on the Mesa 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers in delivery

Tell us what you sell and we’ll find the people at organizations working on delivery most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse Meeting on the Mesa 2026 by

Not affiliated with or endorsed by the Alliance for Regenerative Medicine or the Cell & Gene Meeting on the Mesa. Submit a correction